ArticleJournal of biomedical physics & engineering2022
In-Vitro Evaluation of Novel Polycaprolactone/ Chitosan/ Carbon Nano Tube Scaffold for Tissue Regeneration.
Article in Journal of biomedical physics & engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Poly-ɛ-caprolactone/multi-wall carbon nanotube composites as osteoinductive scaffolds for alveolar bone regeneration.Journal of dental sciences · 2026Article
- A novel antibacterial hydrogel containing aminophylline as a versatile platform for neural differentiation of hWJMSCs through the CREB pathway.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Many patients lose their organs or tissues due to disease, trauma, or a variety of genetic disorders. Tissue engineering is a multidisciplinary science to regenerate or restore tissue or organ function and an appropriate scaffold is the first and certainly a crucial step in tissue engineering strategies. Objective: The purpose of this study is to fabricate and evaluate the in-vitro response of porous nano Polycaprolactone (PCL)/ chitosan/ multi-wall carbon nanotube (MWCNTs) scaffold for tissue regeneration. Material and Methods: In this experimental research, a novel scaffold containing MWCNTs in polycaprolactone/chitosan nanofibrous scaffold was synthesized by electrospinning technique. Results: According to scanning electron microscopy SEM images, by increasing the number of MWCNT in the scaffold by 2%, the average diameter decreased significantly for fabricated scaffolds with 5% MWCNTs. Based on the results, the scaffolds plunged from submicron to nanoscale fibers at about 80 nm. In addition, by adding more MWCNT to the nanofibrous scaffold, the biodegradation rate was decreased by 32%. However, mechanical characterization demonstrates that the higher level of MWCNT increases young modulus by 96%, and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide (MTT) assay illustrated that MWCNTs could enhance bioactivity and cell- scaffold relationship in addition to alkaline phosphatase (ALP). Conclusion: MWCNT significantly improves the physical and mechanical properties of fabricated scaffolds and in-vitro assessment demonstrated that the prepared nanofibrous scaffold containing 4% MWCNT could be a very useful biocompatible material for tissue engineering.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.